22
October

08:30 AM BST

Drug Discovery Biology

Name: Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024
Start: 2024-10-22T08:00
End: 2024-10-22T18:00
Location: Crowne Plaza, London Docklands

&

Bioinformatics

Strategy Meeting Europe 2024

Pushing our understanding of the physiological context and quality of drug target characterisation, validation, and safety profiling throughout the preclinical space

Crowne Plaza London Dockland

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Biology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Biology professionals from across Europe, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

Meet Our Past Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Drug Discovery Biology strategy meeting.

Kam Dhaliwal

Global VP Strategic Alliances Bit.bio

Asif Ahmed

Executive Chairman and CEO MIRZYME

Professor Asif Ahmed is a world-renowned vascular scientist, who established Aston Medical School and is the founder of <a href="https://www.mirzyme.com/">MirZyme Therapeutics</a>, a biopharmaceutical company developing diagnostics and drugs to address the unmet medical needs and prevent disorders of pregnancy. He discovered two protective pathways that put the ‘brakes’ on preeclampsia; a life-threatening condition in pregnancy. He has championed social mobility, international connectivity and translational research. Before becoming the inaugural Pro-Vice-Chancellor for Health in 2012, he was the Gustav Born Chair of Vascular Biology at the University of Edinburgh. He is the recipient of the 7th British Muslim Awards for ‘Services to Education’ in 2019.
Founder of <a href="https://www.mirzyme.com/">MirZyme Therapeutics</a> with globally granted patents to prevent preeclampsia. Discoverer of two protective pathways to stop preeclampsia during pregnancy. Founder of the most socially inclusive medical school in the United Kingdom.
Professor Ahmed is a research-minded visionary communicator and possesses entrepreneurial energy and the ability to identify opportunities for growth. He helps to shape the future direction of organisations with his ability to empower others and encourage them to make meaningful contributions to the organisation and wider society.
Most of Professor Ahmed’s academic life was spent in top research-intensive universities. He moved to Aston to bring about a transformational change in Birmingham by establishing the most socially inclusive medical school in the United Kingdom. He wanted to ensure that the school had innovative medical education, inclusive leadership, and a focus on research at the core of its model, but did not compromise entry standards in selecting students from hard-to-reach backgrounds. His message to his medical school staff was simple “Inspire to Aspire”.
Professor Ahmed’s drive is to ensure that his discoveries translate so that no woman who chooses to have a baby ever needs to fear the silent killer preeclampsia. MirZyme and Professor Ahmed are leading a targeted therapeutic approach to prevent preeclampsia.

Lassina Badolo

Executive Director, Head of DMPK, Early Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca

Muireann Coen

Director, Oncology Discovery Safety Science AstraZeneca

Dr. Muireann Coen is a Director of Oncology Discovery Safety Science at AstraZeneca and a Senior Lecturer in the Department of Surgery and Cancer at Imperial College London. She has recently completed the Academy of Medical Sciences <a href="https://acmedsci.ac.uk/grants-and-schemes/mentoring-and-other-schemes/FLIER">FLIER leadership programme</a>.
Her academic research has involved the development and application of metabolic phenotyping and associated bioinformatic strategies in the field of pre-clinical and clinical hepatotoxicity to further mechanistic understanding of toxicity and ultimately identify translational biomarkers. At AstraZeneca she works on discovery stage projects to apply both traditional and new tools to better identify, define and mitigate safety risks for new targets in the oncology pipeline.
Dr. Coen has published over 75 peer-reviewed papers, is an editorial board member of the British Journal of Pharmacology and Nature Scientific Reports and a member of the British Toxicology Society Scientific Sub-Committee and MRC ITTP committee. She was awarded the BTS early career researcher prize in 2010 and an MRC Integrative Toxicology Training Partnership (ITTP) career development fellowship in 2009.

Klaus Dembowsky

Chief Executive Officer AMCURE GmbH

Vishal Sahni

Director, Corporate Business Development & Strategy Lundbeck

Tarek Samad

Senior Vice President & Global Head, Research LUNDBECK

Magnus Walter

Senior Research Fellow, Head of Discovery Chemistry, Screening Biology and Operations ABBVIE

Jonathan Wingfield

Principal Scientist, Mechanistic Structure and Biophysics, Discovery Sciences, R&D AstraZeneca

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

09:00 – 10:00

Roundtable Tracks

TARGET IDENTIFICATION & HIT VALIDATION
Investigating The Potential Of RNA-based Targets Such As Non Coding RNAs And RNA-Protein Interactions And Developing Strategies For Their Validation In Drug Discovery

DMPK / ADME & TOXICOLOGY
Assessing Current Advancements In PBPK Absorption Modeling And Its Challenges

IN VIVO AND IN VITRO PHARMACOLOGY
Enhancing Preclinical Dose Projection And Prediction To Aid Further Clinical Studies

IN SILICO BIOLOGY / AI & ML
Harnessing The Promise Of Generative AI To Transform Drug Discovery Hence Forward

BIOINFORMATICS / DATA INTEGRATION & DATA MINING
Discussing Empirical Methods In Instituting A Data Driven Drug Discovery

STRATEGIC PARTNERSHIPS, INVESTMENT & BST COLLABORATIONS
Considering Contemporary Techniques In Adapting Go-To-Market Approach

11:10 – 12:10

Roundtable Tracks

TARGET IDENTIFICATION & HIT VALIDATION
Probing Ways To Access Greater Target Space And Expand The Druggable Genome To A Larger Therapeutic Area To Discover New Drugs

SPONSOR

DMPK / ADME & TOXICOLOGY
Integrating Breakthroughs In In Silico In Vivo And In Vitro Pharmacology To Enhance Admet Modeling

SPONSOR

IN VIVO AND IN VITRO PHARMACOLOGY
Identifying The Rein Of Using Animal Models In Pre-Clinical Testing And Combining Current In Vitro Technique To Achieve Desired Result

SPONSOR

IN SILICO BIOLOGY / AI & ML
Leveraging Ai Target Selection Technologies Strategies And Infrastructure Tools To Support Computational Biology

SPONSOR

BIOINFORMATICS / DATA INTEGRATION & DATA MINING
Application Of Systems Biology And Data Integration With AI In Drug Discovery And Development

SPONSOR

STRATEGIC PARTNERSHIPS, INVESTMENT & BST COLLABORATIONS
Crowdsourcing Vs Outsourcing Understanding The Need To Source Solutions From Various Platforms And Approaches To Generate Ideas And Inject Innovations In Drug Discovery And Development

SPONSOR

12:15 – 13:15

Roundtable Tracks

TARGET IDENTIFICATION & HIT VALIDATION
Enumerating Criteria Selection Of Appropriate Modalities And Hit Id Strategies For First In Class Targets

DMPK / ADME & TOXICOLOGY
Exploring The Use Of Organ-On-Achip And Other Microphysiological Systems For High-Throughput Toxicity Screening, ADME Studies And Prediction Of Drug Safety Profiles

IN VIVO AND IN VITRO PHARMACOLOGY
What Are The Latest Wins In Determining Unresolved Pathophysiology Of Some Diseases Like Alzheimers And What Does It Says About The Future Of Drug Discovery?

IN SILICO BIOLOGY / AI & ML
Evaluating Practical Uses Of Latest AI/ML Tools To Expedite And Increase Efficiency In Drug Discovery Process

BIOINFORMATICS / DATA INTEGRATION & DATA MINING
Setting Fundamentals In Data Democratization And The Factors To Consider In Making It Happen

STRATEGIC PARTNERSHIPS, INVESTMENT & BST COLLABORATIONS
Leveraging On Academic Partnerships To Further Drug Discovery And Development Operations

13:15 – 14:00

15:10 – 16:10

Roundtable Tracks

TARGET IDENTIFICATION & HIT VALIDATION
Reducing Attrition Rate By Employing Groundbreaking Technologies At Discovery Stage And Accelerate The Process

DMPK / ADME & TOXICOLOGY
Advances In Computational Models And Machine Learning Techniques For A More Precise Prediction Of ADME Properties And Process

IN VIVO AND IN VITRO PHARMACOLOGY
Evaluating Engineered Organ-On-Chip Technology In Combination With Other Techniques To Address The Problem Of Heterogenous Diseased Population

IN SILICO BIOLOGY / AI & ML
Decoding Omics Data Interpretation, Integration And Application In Drug Discovery Through The Lense Of In Silico Biology

BIOINFORMATICS / DATA INTEGRATION & DATA MINING
Introducing Cutting Edge Bioinformatics Applications In Novel Therapeutic Areas

STRATEGIC PARTNERSHIPS, INVESTMENT & BST COLLABORATIONS
What Are Some Of The Effective Ways To Initiate Financial Strategies Using The Go To Fundraising Model

Hotel & Venue

Crowne Plaza London Docklands

Our hotel is a haven from the hustle & bustle of London life – you’ll find peace & tranquility in modern surroundings. We’re close to The O2 Arena, ExCeL Exhibition Centre & Canary Wharf.

Hotel Details Map & Directions Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Europe

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024

&

Strategy Meeting Europe 2024

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Crowne Plaza London Dockland

Fresh Biology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say...

Meet Our Past Facilitators

Kam Dhaliwal

Asif Ahmed

Lassina Badolo

Muireann Coen

Klaus Dembowsky

Vishal Sahni

Tarek Samad

Magnus Walter

Jonathan Wingfield

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

OPENING KEYNOTE PRESENTATION

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Refreshment Break

Networking/1-1 Meetings

Roundtable ( Solutions )

Roundtable Tracks

SPONSOR

SPONSOR

SPONSOR

SPONSOR

SPONSOR

SPONSOR

Roundtable

Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable ( Pharma / Biotech)

Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

Drinks Canapes Reception

Hotel & Venue

Crowne Plaza London Docklands

Our 2024 Partnering Sponsors

Our 2024 Media Partners

Our Past Co-Hosts

Want to find out more?

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Crowne Plaza London Dockland